tiprankstipranks
Kezar Life Sciences Inc (KZR)
NASDAQ:KZR
US Market

Kezar Life Sciences Income Statement

Last quarter (Q3 2024), Kezar Life Sciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Kezar Life Sciences's net income was $-20.31M. See Kezar Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 7.00M$ ―$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 1.10M$ 1.00M$ 900.00K$ 900.00K$ 900.00K
EBITDA
$ -99.25M$ -66.03M$ -52.96M$ -40.20M$ -34.77M
Operating Income
$ -111.42M$ -71.16M$ -54.66M$ -42.95M$ -37.34M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -101.87M$ -68.24M$ -54.63M$ -41.74M$ -35.09M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Kezar Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis